Open AccessPB2103: CAN WE ACCURATELY PREDICT SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA IN THE RITUXIMAB ERA? RETROSPECTIVE COMPARISON OF IPI, AAIPI, R‐IPI AND NCCN‐IPI
Author(s) -
Chorão P.,
Henriques M.,
Baptista P.,
Carvalhais I.,
Pinto A. L.,
Silva P.,
Carneiro A. M.,
Ferreira F.,
Trigo F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851244.27592.9f
Subject(s) - international prognostic index , medicine , diffuse large b cell lymphoma , rituximab , oncology , vincristine , lymphoma , performance status , gastroenterology , cyclophosphamide , cancer , chemotherapy